Changes of N6-methyladenosine modulators promote breast cancer progression

BACKGROUND: Breast cancer (BC) displays striking genetic, epigenetic and phenotypic diversity. N(6)-methyladenosine (m6A) in mRNA has emerged as a crucial epitranscriptomic modification that controls cancer self-renewal and cell fate. However, the key enzymes of m6A expression and function in human...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lianpin, Wu, Dengying, Ning, Jinfeng, Liu, Wei, Zhang, Donghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451293/
https://www.ncbi.nlm.nih.gov/pubmed/30953473
http://dx.doi.org/10.1186/s12885-019-5538-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451293/
https://www.ncbi.nlm.nih.gov/pubmed/30953473
http://dx.doi.org/10.1186/s12885-019-5538-z

Ejemplares similares